MILLENNIUM MANAGEMENT LLC - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$11,000
-88.8%
24,056
-18.7%
0.00%
Q2 2021$98,000
-46.7%
29,576
-15.5%
0.00%
Q4 2020$184,000
-51.6%
34,987
-48.3%
0.00%
Q3 2020$380,000
-55.9%
67,616
-36.8%
0.00%
-100.0%
Q2 2020$861,000
-33.7%
106,922
+5.4%
0.00%
-66.7%
Q1 2020$1,299,000101,4180.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Hayden Royal, LLC 20,642$91,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 173,202$762,0000.01%
SG3 Management, LLC 50,000$220,0000.01%
Ameritas Investment Partners, Inc. 378$2,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 9,817$43,0000.00%
UBS Group AG 2,841$13,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 3,926$17,0000.00%
BANK OF AMERICA CORP /DE/ 11,642$51,0000.00%
WELLS FARGO & COMPANY/MN 13,762$61,0000.00%
NORTHERN TRUST CORP 78,993$348,0000.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders